Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 682-688

  Kim, B S ^a   Jung, H S ^a   Bang, O Y ^a   Chung, C S ^a   Lee, K H ^a   Kim, G M ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Atherosclerosis; Carotid stenosis; Lipoprotein(a); Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; WARFARIN;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BLOOD SAMPLING; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; INTRACRANIAL AND EXTRACRANIAL ARTERY STENOSIS; KOREA; LARGE ARTERY ATHEROSCLEROSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON CEREBRAL STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOGRAPHY; CAROTID STENOSIS; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIA; LIPOPROTEIN(A); MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 77957690844     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.007     Document Type: Article

References (37)

1. Berglund L., Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004, 24:2219-2226.
2. Utermann G. The mysteries of lipoprotein(a). Science 1989, 246:904-910.
3. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000, 102:1082-1085.
4. Ariyo A.A., Thach C., Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003, 349:2108-2115.
5. Smolders B., Lemmens R., Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke 2007, 38:1959-1966.
6. Dangas G., Mehran R., Harpel P.C., et al. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998, 32:2035-2042.
7. Tsimikas S., Brilakis E.S., Miller E.R., et al. Oxidized phospholipids, lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005, 353:46-57.
8. Arenillas J.F., Molina C.A., Chacon P., et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004, 63:27-32.
9. Klein J.H., Hegele R.A., Hackam D.G., Koschinsky M.L., Huff M.W., Spence J.D. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol 2008, 28:1851-1856.
10. Feldmann E., Wilterdink J.L., Kosinski A., et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (sonia) trial. Neurology 2007, 68:2099-2106.
11. Liu H.M., Tu Y.K., Yip P.K., Su C.T. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in taiwan chinese patients with mr angiography: preliminary experience. Stroke 1996, 27:650-653.
12. Lee S.J., Cho S.J., Moon H.S., et al. Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol 2003, 60:1561-1564.
13. Takahashi W., Ohnuki T., Ide M., Takagi S., Shinohara Y. Stroke risk of asymptomatic intra- and extracranial large-artery disease in apparently healthy adults. Cerebrovasc Dis 2006, 22:263-270.
14. Wong K.S., Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003, 34:2361-2366.
15. Nagao T., Sadoshima S., Ibayashi S., Takeya Y., Fujishima M. Increase in extracranial atherosclerotic carotid lesions in patients with brain ischemia in Japan. An angiographic study. Stroke 1994, 25:766-770.
16. Debrey S.M., Yu H., Lynch J.K., et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. Stroke 2008, 39:2237-2248.
17. McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 2004, 164:697-705.
18. Porkka K.V., Erkkola R., Taimela S., Raitakari O.T., Dahlen G.H., Viikari J.S. Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors. Ann Med 1995, 27:193-198.
19. Haffner S.M., Gruber K.K., Aldrete G., Morales P.A., Stern M.P., Tuttle K.R. Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 1992, 3:1156-1162.
20. Bang O.Y., Lee P.H., Joo S.Y., Lee J.S., Joo I.S., Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003, 54:227-234.
21. Smaha L.A. The American heart association get with the guidelines program. Am Heart J 2004, 148:S46-48.
22. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 1993, 24:35-41.
23. Reynolds K., Lewis B., Nolen J.D., Kinney G.L., Sathya B., He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003, 289:579-588.
24. Yun K.E., Park H.S., Song Y.M., Cho S.I. Increases in body mass index over a 7-year period and risk of cause-specific mortality in Korean men. Int J Epidemiol 2009.
25. Takahashi W., Ohnuki T., Ohnuki Y., Kawada S., Takagi S. The role of high-sensitivity c-reactive protein in asymptomatic intra- and extracranial large artery diseases. Cerebrovasc Dis 2008, 26:549-555.
26. Samuels O.B., Joseph G.J., Lynn M.J., Smith H.A., Chimowitz M.I. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000, 21:643-646.
27. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1991, 325:445-453.
28. Bang O.Y., Kim J.W., Lee J.H., et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005, 65:296-298.
29. Cerrato P., Imperiale D., Fornengo P., et al. Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease. Neurology 2002, 58:653-655.
30. Petersen N.H., Schmied A.B., Zeller J.A., Plendl H., Deuschl G., Zunker P. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke. Cerebrovasc Dis 2007, 23:188-193.
31. Schlaich M.P., John S., Langenfeld M.R., Lackner K.J., Schmitz G., Schmieder R.E. Does lipoprotein(a) impair endothelial function?. J Am Coll Cardiol 1998, 31:359-365.
32. Jamieson D.G., Usher D.C., Rader D.J., Lavi E. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am J Pathol 1995, 147:1567-1574.
33. Yasaka M., Yamaguchi T., Shichiri M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 1993, 24:206-211.
34. de Weerd M., Greving J.P., de Jong A.W., Buskens E., Bots M.L. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009, 40:1105-1113.
35. Lorenz M.W., Karbstein P., Markus H.S., Sitzer M. High-sensitivity c-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007, 38:1774-1779.
36. Kargman D.E., Tuck C., Berglund L., et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the northern manhattan stroke study. Atherosclerosis 1998, 139:391-399.
37. Taylor A.J., Villines T.C., Stanek E.J., et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009, 361:2113-2122.